Prevention of Irinotecan Induced Diarrhea by Probiotics
Phase 3
Completed
- Conditions
- DiarrheaCancer
- Interventions
- Drug: Probio-Tec® BG-VCap-6.5Drug: Placebo
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- S&D Pharma SK s.r.o.
- Target Recruit Count
- 233
- Registration Number
- NCT02819960
- Locations
- 🇸🇰
National Cancer Institute, Bratislava, Slovakia
Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients
Phase 2
- Conditions
- Febrile NeutropeniaNeutropeniaInfection in an Immunocompromised HostCancer
- Interventions
- Other: PlaceboDietary Supplement: Probio-Fix InumDietary Supplement: Beneo Synergy 1
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- S&D Pharma SK s.r.o.
- Target Recruit Count
- 120
- Registration Number
- NCT02544685
- Locations
- 🇸🇰
University Children's Hospital Banska Bystrica, Banska Bystrica, Slovakia
© Copyright 2025. All Rights Reserved by MedPath